Patents by Inventor Denise Zarins

Denise Zarins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12114915
    Abstract: Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may be useful in the treatment of infertility associated with PCOS.
    Type: Grant
    Filed: March 21, 2024
    Date of Patent: October 15, 2024
    Assignee: May Health US Inc.
    Inventors: Denise Zarins, Neil Barman, Garrett Schwab, Roger Osborne, Douglas Sutton
  • Publication number: 20240335226
    Abstract: The present disclosure relates to devices, systems and methods for evaluating the success of a treatment applied to tissue in a patient, such as a radio frequency ablative treatment used to neuromodulate nerves associated with the renal artery. A system monitors parameters or values generated during the course of a treatment. Feedback provided to an operator is based on the monitored values and relates to an assessment of the likelihood that a completed treatment was technically successful. In other embodiments, parameters or values generated during the course of an incomplete treatment (such as due to high temperature or high impedance conditions) may be evaluated to provide additional instructions or feedback to an operator.
    Type: Application
    Filed: June 20, 2024
    Publication date: October 10, 2024
    Inventors: Sowmya Ballakur, Robert J. Beetel, Paul Friedrichs, David Herzfeld, Andrew Wu, Denise Zarins, Mark S. Leung
  • Publication number: 20240245455
    Abstract: Microwave catheter apparatuses, systems, and methods for achieving renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a catheter treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a microwave transmission element to a renal artery via an intravascular path. Renal neuromodulation may be achieved via dielectric heating in the presence of microwave irradiation that modulates neural fibers that contribute to renal function or alters vascular structures that feed or perfuse the neural fibers.
    Type: Application
    Filed: March 6, 2024
    Publication date: July 25, 2024
    Inventors: Karun D. Naga, Roman Turovskiy, Denise Zarins, Mark Gelfand, Arye Rosen
  • Patent number: 12035959
    Abstract: The present disclosure relates to devices, systems and methods for evaluating the success of a treatment applied to tissue in a patient, such as a radio frequency ablative treatment used to neuromodulate nerves associated with the renal artery. A system monitors parameters or values generated during the course of a treatment. Feedback provided to an operator is based on the monitored values and relates to an assessment of the likelihood that a completed treatment was technically successful. In other embodiments, parameters or values generated during the course of an incomplete treatment (such as due to high temperature or high impedance conditions) may be evaluated to provide additional instructions or feedback to an operator.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: July 16, 2024
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Sowmya Ballakur, Robert J. Beetel, Paul Friedrichs, David Herzfeld, Andrew Wu, Denise Zarins, Mark S. Leung
  • Publication number: 20240225723
    Abstract: Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may be useful in the treatment of infertility associated with PCOS.
    Type: Application
    Filed: March 21, 2024
    Publication date: July 11, 2024
    Applicant: May Health US Inc.
    Inventors: Denise ZARINS, Neil BARMAN, Garrett SCHWAB, Roger OSBORNE, Douglas SUTTON
  • Patent number: 11974804
    Abstract: Methods and apparatus are provided for treating hypertension, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: May 7, 2024
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Denise Zarins, Hanson Gifford, III, Mark E. Deem, Douglas Sutton, Howard R. Levin, Mark Gelfand
  • Patent number: 11963714
    Abstract: Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: April 23, 2024
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Mark E. Deem, Hanson S. Gifford, III, Denise Zarins, Douglas Sutton, Erik Thai, Mark Gelfand, Howard R. Levin
  • Patent number: 11963718
    Abstract: Microwave catheter apparatuses, systems, and methods for achieving renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a catheter treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a microwave transmission element to a renal artery via an intravascular path. Renal neuromodulation may be achieved via dielectric heating in the presence of microwave irradiation that modulates neural fibers that contribute to renal function or alters vascular structures that feed or perfuse the neural fibers.
    Type: Grant
    Filed: May 19, 2021
    Date of Patent: April 23, 2024
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Karun D. Naga, Roman Turovskiy, Denise Zarins, Mark Gelfand, Arye Rosen
  • Patent number: 11937870
    Abstract: Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may be useful in the treatment of infertility associated with PCOS.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: March 26, 2024
    Assignee: May Health US Inc.
    Inventors: Denise Zarins, Neil Barman, Garrett Schwab, Roger Osborne, Douglas Sutton
  • Publication number: 20240041512
    Abstract: Methods and system are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues. In some embodiments, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy.
    Type: Application
    Filed: October 5, 2023
    Publication date: February 8, 2024
    Inventors: Andrew Wu, Benjamin Clark, Erik Thai, Nicolas Zadno, Denise Zarins
  • Publication number: 20230404662
    Abstract: Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.
    Type: Application
    Filed: August 30, 2023
    Publication date: December 21, 2023
    Inventors: Andrew Wu, Benjamin J. Clark, Denise Zarins, Erik Thai
  • Patent number: 11801085
    Abstract: Methods and system are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues. In some embodiments, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: October 31, 2023
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Andrew Wu, Benjamin J. Clark, Erik Thai, Nicolas Zadno, Denise Zarins
  • Patent number: 11793564
    Abstract: Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may be useful in the treatment of infertility associated with PCOS.
    Type: Grant
    Filed: January 30, 2023
    Date of Patent: October 24, 2023
    Assignee: May Health US Inc.
    Inventors: Denise Zarins, Neil Barman, Garrett Schwab, Roger Osborne, Douglas Sutton
  • Publication number: 20230277240
    Abstract: Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.
    Type: Application
    Filed: April 21, 2023
    Publication date: September 7, 2023
    Inventors: Andrew Wu, Benjamin J. Clark, Denise Zarins, Erik Thai
  • Publication number: 20230233249
    Abstract: Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may be useful in the treatment of infertility associated with PCOS.
    Type: Application
    Filed: January 30, 2023
    Publication date: July 27, 2023
    Applicant: May Health US Inc.
    Inventors: Denise ZARINS, Neil BARMAN, Garrett SCHWAB, Roger OSBORNE, Douglas SUTTON
  • Patent number: 11666380
    Abstract: Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: June 6, 2023
    Assignee: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
    Inventors: Andrew Wu, Benjamin J. Clark, Denise Zarins, Erik Thai
  • Publication number: 20220361774
    Abstract: Systems, devices, and methods for performing trans-abdominal fetal oximetry and/or trans-abdominal fetal pulse oximetry using physiological characteristics and/or a calibration factor may receive a physiological characteristic of a pregnant mammal and determine one or more potential impact(s) of the physiological characteristic on a behavior of an optical signal projected into the abdomen of the pregnant mammal Then a calibration factor for the optical signal responsively to the impact. The calibration factor may then be used to calibrate a fetal detected electronic signal so that a level of fetal hemoglobin oxygen saturation may be determined.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 17, 2022
    Inventors: NEIL PADHARIA RAY, MARK ANDREW ROSEN, ADAM JACOBS, RODNEY P. CHIN, DAVID BOAS, JANA M. KAINERSTORFER, RUSSELL DELONZOR, DENISE ZARINS
  • Publication number: 20220079666
    Abstract: Catheter apparatuses, systems, and methods for achieving renal neuromodulation by intravascular access are disclosed herein. One aspect of the present technology, for example, is directed to a treatment device having a multi-electrode array configured to be delivered to a renal blood vessel. The array is selectively transformable between a delivery or low-profile state (e.g., a generally straight shape) and a deployed state (e.g., a radially expanded, generally helical shape). The multi-electrode array is sized and shaped so that the electrodes or energy delivery elements contact an interior wall of the renal blood vessel when the array is in the deployed (e.g., helical) state. The electrodes or energy delivery elements are configured for direct and/or indirect application of thermal and/or electrical energy to heat or otherwise electrically modulate neural fibers that contribute to renal function or of vascular structures that feed or perfuse the neural fibers.
    Type: Application
    Filed: September 10, 2021
    Publication date: March 17, 2022
    Inventors: Vincent Ku, Robert Beetel, Andrew Wu, Denise Zarins, Maria Aboytes
  • Patent number: 11213674
    Abstract: Catheter assemblies for neuromodulation proximate a renal artery bifurcation and associated systems and methods are disclosed herein. A catheter assembly configured in accordance with a particular embodiment of the present technology can include a shaft having a proximal portion, a distal portion, and two therapeutic arms extending from the distal portion. The shaft can be configured to deliver the distal portion to a treatment site proximate a branch point or bifurcation in a renal blood vessel. The therapeutic arms can include energy delivery elements that are configured to deliver the therapeutically-effective energy to renal nerves proximate the branch point.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: January 4, 2022
    Assignee: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
    Inventors: Neil C. Barman, Robert J. Beetel, Benjamin J. Clark, Andrew Wu, Maria G. Aboytes, Denise Zarins
  • Publication number: 20210369334
    Abstract: Methods and apparatus are provided for pulsed electric field neuromodulation via an intra-to-extravascular approach, e.g., to effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, changes in cytokine upregulation and other conditions in target neural fibers. In some embodiments, the ITEV PEF system comprises an intravascular catheter having one or more electrodes configured for intra-to-extravascular placement across a wall of patient's vessel into proximity with target neural fibers. With the electrode(s) passing from an intravascular position to an extravascular position prior to delivery of the PEF, a magnitude of applied voltage or energy delivered via the electrode(s) and necessary to achieve desired neuromodulation may be reduced relative to an intravascular PEF system having one or more electrodes positioned solely intravascularly.
    Type: Application
    Filed: August 17, 2021
    Publication date: December 2, 2021
    Inventors: Denise Zarins, Benjamin J. Clark, Nicolas Zadno, Hanson S. Gifford, III, Erik Thai